BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10690618)

  • 1. Marginal donors in liver transplantation.
    Loinaz C; González EM
    Hepatogastroenterology; 2000; 47(31):256-63. PubMed ID: 10690618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptance of marginal liver donors increases the volume of liver transplant: early results of a single-center experience.
    Gruttadauria S; Cintorino D; Mandala' L; Musumeci A; Volpes R; Vizzini GB; Palazzo U; Spada M; Verzaro R; Gridelli B
    Transplant Proc; 2005; 37(6):2567-8. PubMed ID: 16182745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting graft survival after liver transplantation from donation after cardiac death donors.
    Lee KW; Simpkins CE; Montgomery RA; Locke JE; Segev DL; Maley WR
    Transplantation; 2006 Dec; 82(12):1683-8. PubMed ID: 17198260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of marginal donors in liver transplantation. The Hungarian experience].
    Nemes B; Gelley F; Zádori G; Görög D; Fehérvári I; Jakab K; Fazakas J; Mándli T; Gerlei Z; Sárváry E; Doros A; Kóbori L
    Orv Hetil; 2009 Dec; 150(49):2228-36. PubMed ID: 19939784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The marginal donor: a single-center experience in orthotopic liver transplantation.
    Scuderi V; Ceriello A; Maida P; Aragiusto G; Arenga G; Carfora T; Defez M; Giuliani A; Monti GN; Santaniello W; Sicoli F; Calise F
    Transplant Proc; 2006 May; 38(4):1069-73. PubMed ID: 16757267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An approach to the rational use of steatotic donor livers in liver transplantation.
    Urena MA; Moreno Gonzalez E; Romero CJ; Ruiz-Delgado FC; Moreno Sanz C
    Hepatogastroenterology; 1999; 46(26):1164-73. PubMed ID: 10370686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry.
    Smith CM; Davies DB; McBride MA
    Clin Transpl; 1999; ():23-34. PubMed ID: 11038623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usage of marginal organs for liver transplantation: a way around the critical organ shortage?].
    Pratschke S; Loehe F; Graeb C; Jauch KW; Angele MK
    Zentralbl Chir; 2009 Apr; 134(2):107-12. PubMed ID: 19382040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of marginal donors to liver transplantation for hepatitis C virus infection.
    Briceño J; Ciria R; Pleguezuelo M; Naranjo A; Sánchez-Hidalgo J; Ruiz-Rabelo J; López-Cillero P; Luque A; de la Mata M; Rufián S
    Transplant Proc; 2007 Sep; 39(7):2297-9. PubMed ID: 17889169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation in the United States.
    Qiu J; Ozawa M; Terasaki PI
    Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the use of marginal liver donors change recipient survival rate?
    Rocha MB; Boin IF; Escanhoela CA; Leonardi LS
    Transplant Proc; 2004 May; 36(4):914-5. PubMed ID: 15194314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birmingham liver unit: use of marginal donors for liver transplantation.
    Starkey G; Buckels J
    Clin Transpl; 2008; ():137-42. PubMed ID: 19708452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation.
    Nikeghbalian S; Nejatollahi SM; Salahi H; Bahador A; Sabet B; Jalaeian H; Geramizadeh B; Dehghani SM; Malek-Hosseini SA
    Transplant Proc; 2007 May; 39(4):1181-3. PubMed ID: 17524926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended criteria donors in liver transplantation: adapting donor quality and recipient.
    Gastaca M
    Transplant Proc; 2009 Apr; 41(3):975-9. PubMed ID: 19376402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donors older than 70 years in liver transplantation.
    Gastaca M; Valdivieso A; Pijoan J; Errazti G; Hernandez M; Gonzalez J; Fernandez J; Matarranz A; Montejo M; Ventoso A; Martinez G; Fernandez M; de Urbina JO
    Transplant Proc; 2005 Nov; 37(9):3851-4. PubMed ID: 16386560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elderly donors for HCV(+) versus non-HCV recipients: patient survival following liver transplantation.
    Boin IF; Ataide EC; Leonardi MI; Stucchi R; Sevá-Pereira T; Pereira IW; Cardoso AR; Caruy CA; Luzo A; Leonardi LS
    Transplant Proc; 2008 Apr; 40(3):792-6. PubMed ID: 18455019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation.
    Ho KJ; Owens CD; Johnson SR; Khwaja K; Curry MP; Pavlakis M; Mandelbrot D; Pomposelli JJ; Shah SA; Saidi RF; Ko DS; Malek S; Belcher J; Hull D; Tullius SG; Freeman RB; Pomfret EA; Whiting JF; Hanto DW; Karp SJ
    Transplantation; 2008 Jun; 85(11):1588-94. PubMed ID: 18551064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.